Financial News

NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories, Inc. (BDR)

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has now determined to immediately suspend trading in the common stock of Blonder Tongue Laboratories, Inc. (the “Company”) ─ ticker symbol BDR ─ from the Exchange. This follows the Exchange’s December 10, 2021 announcement initiating delisting proceedings.

The Company had requested a review of the NYSE American delisting determination before a Committee of the Board of Directors of the Exchange. On June 24, 2022, the Company provided formal notification of its intention to withdraw its request for such review.

Accordingly, the NYSE American will now suspend trading in the common stock and will file a delisting application with the Securities and Exchange Commission.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.82
-10.55 (-4.10%)
AAPL  342.56
-6.65 (-1.90%)
AMD  424.39
-64.80 (-13.25%)
BAC  47.04
-1.53 (-3.15%)
GOOG  264.00
-7.02 (-2.59%)
META  560.84
-35.38 (-5.93%)
MSFT  484.52
-13.78 (-2.77%)
NVDA  125.53
-20.45 (-14.01%)
ORCL  101.19
-9.38 (-8.48%)
TSLA  345.82
-28.59 (-7.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback